Molecular targeting therapy for pancreatic cancer: current knowledge and perspectives from bench to bedside

被引：38
作者：
Furukawa, Toru [1 ]
机构：
[1] Tokyo Womens Med Univ, Int Res & Educ Inst Integrated Med Sci, Shinjuku Ku, Tokyo 1628666, Japan
来源：
JOURNAL OF GASTROENTEROLOGY | 2008年 / 43卷 / 12期
关键词：
pancreatic cancer; molecular targeting; RAS-MAPK; PI3K-AKT; hedgehog;
D O I：
10.1007/s00535-008-2226-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Current medical interventions for pancreatic cancer are insufficient. Recent molecular investigations have elucidated complex genetic mechanisms of cancer that especially involve multiple signal transduction pathways; this enables us to develop molecular medicines targeting specific genetic molecules in the pathways. These molecular medicines seem to promise clues for curing cancers, including pancreatic cancer. This review describes current knowledge and perspectives regarding the development of molecular medicines for pancreatic cancer by focusing on growth factor receptor systems and three major signal transduction pathways: the RAS-MAPK, PI3K-AKT-mTOR, and hedgehog pathways.
引用
收藏
页码：905 / 911
页数：7
相关论文
共 50 条
  • [41] Targeting the complexity of Src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy
    Parkin, Ashleigh
    Man, Jennifer
    Timpson, Paul
    Pajic, Marina
    FEBS JOURNAL, 2019, 286 (18) : 3510 - 3539
  • [42] MDA-7/IL-24 as a cancer therapeutic: from bench to bedside
    Dent, Paul
    Yacoub, Adly
    Hamed, Hossein A.
    Park, Margaret A.
    Dash, Rupesh
    Bhutia, Sujit K.
    Sarkar, Devanand
    Gupta, Pankaj
    Emdad, Luni
    Lebedeva, Irina V.
    Sauane, Moira
    Su, Zhao-Zhong
    Rahmani, Mohamed
    Broaddus, William C.
    Young, Harold F.
    Lesniak, Maciej
    Grant, Steven
    Curiel, David T.
    Fisher, Paul B.
    ANTI-CANCER DRUGS, 2010, 21 (08) : 725 - 731
  • [43] Molecular therapeutic strategies targeting pancreatic cancer induced cachexia
    Yakovenko, Anastasiya
    Cameron, Miles
    Trevino, Jose Gilberto
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 10 (09): : 95 - 106
  • [44] Targeting tumor tolerance: A new hope for pancreatic cancer therapy?
    Delitto, Daniel
    Wallet, Shannon M.
    Hughes, Steven J.
    PHARMACOLOGY & THERAPEUTICS, 2016, 166 : 9 - 29
  • [45] Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer
    Manegold, Philipp
    Lai, Keane K. Y.
    Wu, Yongfeng
    Teo, Jia-Ling
    Lenz, Heinz-Josef
    Genyk, Yuri S.
    Pandol, Stephen J.
    Wu, Kaijin
    Lin, David P.
    Chen, Yibu
    Cu Nguyen
    Zhao, Yi
    Kahn, Michael
    CANCERS, 2018, 10 (04)
  • [46] Gene therapy for pancreatic cancer - current and prospective strategies
    Halloran, CM
    Ghaneh, P
    Neoptolemos, JP
    Costello, E
    SURGICAL ONCOLOGY-OXFORD, 2000, 9 (04): : 181 - 191
  • [47] Novel perspective in pancreatic cancer therapy: Targeting ferroptosis pathway
    Yang, Yang
    Zhang, Zi-Jian
    Wen, Yu
    Xiong, Li
    Huang, Yun-Peng
    Wang, Yong-Xiang
    Liu, Kai
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 13 (11) : 1668 - 1679
  • [48] The development of fluorescence guided surgery for pancreatic cancer: from bench to clinic
    Lwin, Thinzar M.
    Hoffman, Robert M.
    Bouvet, Michael
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (07) : 651 - 662
  • [49] Pancreatic stellate cells and pancreas cancer: Current perspectives and future strategies
    Haqq, Jonathan
    Howells, Lynne M.
    Garcea, Giuseppe
    Metcalfe, Matthew S.
    Steward, Will P.
    Dennison, Ashley R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (15) : 2570 - 2582
  • [50] Targeting Notch signaling in pancreatic cancer patients - rationale for new therapy
    Mysliwiec, P.
    Boucher, M. J.
    ADVANCES IN MEDICAL SCIENCES, 2009, 54 (02): : 136 - 142
12345